Camou, F.; Issa, N.; Hessamfar, M.; Guisset, O.; Mourissoux, G.; Pedeboscq, S.; Minot, A.; Bonnet, F.
Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients? J. Clin. Med. 2022, 11, 5559.
https://doi.org/10.3390/jcm11195559
AMA Style
Camou F, Issa N, Hessamfar M, Guisset O, Mourissoux G, Pedeboscq S, Minot A, Bonnet F.
Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients? Journal of Clinical Medicine. 2022; 11(19):5559.
https://doi.org/10.3390/jcm11195559
Chicago/Turabian Style
Camou, Fabrice, Nahéma Issa, Mojgan Hessamfar, Olivier Guisset, Gaëlle Mourissoux, Stéphane Pedeboscq, Aimée Minot, and Fabrice Bonnet.
2022. "Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?" Journal of Clinical Medicine 11, no. 19: 5559.
https://doi.org/10.3390/jcm11195559
APA Style
Camou, F., Issa, N., Hessamfar, M., Guisset, O., Mourissoux, G., Pedeboscq, S., Minot, A., & Bonnet, F.
(2022). Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients? Journal of Clinical Medicine, 11(19), 5559.
https://doi.org/10.3390/jcm11195559
